ANG II-induced neointimal growth is mediated via cPLA2- and PLD2-activated Akt in balloon-injured rat carotid artery

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 6 58-6, 2005, Pages

  Li, Fang ^a   Zhang, Chunxiang ^a   Schaefer, Susan ^a   Estes, Anne ^a   Malik, Kafait U ^a,b  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Angiotensin II; Cytosolic phospholipase A2; Phospholipase D 2; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN; PHOSPHOLIPASE A2; PHOSPHOLIPASE D2; PROTEIN KINASE B; SMALL INTERFERING RNA;

ADENOVIRUS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON; CAROTID ARTERY INJURY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; INTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; RETROVIRUS; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; BALLOON DILATATION; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; MALE; PHOSPHOLIPASE D; PHOSPHOLIPASES A; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 28144438794     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00450.2005     Document Type: Article

References (56)

1. Abe J, Deguchi J, Matsumoto T, Takuwa N, Noda M, Ohno M, Makuuchi M, Kurokawa K, and Takuwa Y, Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: a link between angiotensin II and intimal thickening. Circulation 96: 1906-1913, 1997.
2. 2-mediated release of arachidonic acid is critical for proliferation of vascular smooth muscle cells. J Biol Chem 272: 30504-30511, 1997.
3. 2 and signal transduction. J Am Soc Nephrol 3: 128-150, 1992.
4. Chen Z, Fukutomi T, Zago AC, Ehlers R, Detmers PA, Wright SD, Rogers C, and Simon DI. Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids. Circulation 106: 20-23, 2002.
5. Daemen MJ, Lombardi DM, Bosman FT, and Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 68: 450-456, 1991.
6. Egan KM, Lawson JA, Fries S, Koller B, Rader DJ, Smyth EM, and Fitzgerald GA. COX-2-derived prostacyclin confers atheroprotection on female mice. Science 306: 1954-1957, 2004.
7. Eto H, Biro S, Miyata M, Kaieda H, Obata H, Kihara T, Orihara K, and Tei C. Angiotensin II type 1 receptor participates in extracellular matrix production in the late stage of remodeling after vascular injury. Cardiovasc Res 59: 200-211, 2003.
8. Freeman EJ. The ANG II-induced growth of vascular smooth muscle cells involves a phospholipase D-mediated signaling mechanism. Arch Biochem Biophys 374: 363-370, 2000.
9. 1 angiotensin receptors coupled to phospholipase D activation. Biochem J 304: 543-548, 1994.
10. Garl PJ, Wenzlau JM, Walker HA, Whitelock JM, Costell M, and Weiser-Evans MC. Perlecan-induced suppression of smooth muscle cell proliferation is mediated through increased activity of the tumor suppressor PTEN. Circ Res 94: 175-183, 2004.
11. Geisterfer AA, Peach MJ, and Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62: 749-756, 1988.
12. Giachelli CM, Majesky MW, and Schwartz SM. Developmentally regulated cytochrome P-450IA1 expression in cultured rat vascular smooth muscle cells. J Biol Chem 266: 3981-3986, 1991.
13. Hardt SE and Sadoshima J. Glycogen synthase kinase-3β: a novel regulator of cardiac hypertrophy and development. Circ Res 90: 1055-1063, 2002.
14. Hutchinson HG, Hein L, Fujinaga M, and Pratt RE. Modulation of vascular development and injury by angiotensin II. Cardiovasc Res 41: 689-700, 1999.
15. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, and Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 15: 1667-1687, 1990.
16. Kawamura M, Terashita Z, Okuda H, Imura Y, Shino A, Nakao M, and Nishikawa K. TCV-116, a novel angiotensin II receptor antagonist, prevents intimal thickening and impairment of vascular function after carotid injury in rats. J Pharmacol Exp Ther 266: 1664-1669, 1993.
17. Kim S, Kawamura M, Wanibuchi H, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, and Iwao H. Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery. Circulation 92: 88-95, 1995.
18. Kino H, Hama J, Takenaka T, Sugimura K, Kamoi K, Shimada S, Yamamoto Y, Nagata S, Horiuchi M, and Katori R Effect of an angiotensin II receptor antagonist, TCV-116, on rat carotid artery neointimal formation after balloon injury. Blood Press Suppl 5: 43-48, 1994.
19. Kitamoto S, Egashira K, and Takeshita A. Stress and vascular responses: anti-inflammatory therapeutic strategy against atherosclerosis and restenosis after coronary intervention. J Pharmacol Sci 91: 192-196, 2003.
20. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, Sessa WC, and Walsh K. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6: 1004-1010, 2000.
21. 2. Am J Physiol Heart Circ Physiol 288: H2306-H2316, 2005.
22. Li F and Malik KU. Angiotensin II-induced Akt activation through the epidermal growth factor receptor in vascular smooth muscle cells is mediated by phospholipid metabolites derived by activation of phospholipase D. J Pharmacol Exp Ther 312: 1043-1054, 2005.
23. Malik KU. Interaction of arachidonic acid metabolites and adrenergic nervous system. Am J Med Sci 295: 280-286, 1988.
24. Mourani PM, Garl PJ, Wenzlau JM, Carpenter TC, Stenmark KR, and Weiser-Evans MC. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN. Circulation 109: 1299-1306, 2004.
25. 2 in norepinephrine- induced arachidonic acid release in rabbit aortic smooth muscle cells. J Biol Chem 271: 30149-30157, 1996.
26. Natarajan R and Nadler JL. Lipoxygenases and lipid signaling in vascular cells in diabetes. Front Biosci 8: 783-795, 2003.
27. Natarajan R and Reddy MA. HETEs/EETs in renal glomerular and epithelial cell functions. Curr Opin Pharmacol 3: 198-203, 2003.
28. Osterrieder W, Muller RK, Powell JS, Clozel JP, Hefti F, and Baumgartner HR. Role of angiotensin II in injury-induced neointima formation in rats. Hypertension 18: II60-II64, 1991.
29. Park KW, Kim DH, You HJ, Sir JJ, Jeon SI, Youn SW, Yang HM, Skurk C, Park YB, Walsh K, and Kim HS. Activated forkhead transcription factor inhibits neointimal hyperplasia after angioplasty through induction of p27. Arterioscler Thromb Vasc Biol 25: 742-747, 2005.
30. 2 in response to norepinephrine. J Biol Chem 276: 15704-15711, 2001.
31. Parmentier JH, Smelcer P, Pavicevic Z, Basic E, Idrizovic A, Estes A, and Malik KU. PKC-ζ mediates norepinephrine-induced phospholipase D activation and cell proliferation in VSMC. Hypertension 41: 794-800, 2003.
32. Powell JS, Clozel JP, Muller RK, Kuhn H, Hefti F, Hosang M, and Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245: 186-188, 1989.
33. 1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol 139: 1291-1296, 1991.
34. Rao GN, Baas AS, Glasgow WC, Eling TE, Runge MS, and Alexander RW. Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells. J Biol Chem 269: 32586-32591, 1994.
35. Rizzo M and Romero G. Pharmacological importance of phospholipase D and phosphatidic acid in the regulation of the mitogen-activated protein kinase cascade. Pharmacol Ther 94: 35-50, 2002.
36. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185, 2002.
37. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993.
38. Schwartz SM, deBlois D, and O'Brien ER. The intima. Soil for atherosclerosis and restenosis. Circ Res 77: 445-465, 1995.
39. Shigematsu K, Koyama H, Olson NE, Cho A, and Reidy MA. Phosphatidylinositol 3-kinase signaling is important for smooth muscle cell replication after arterial injury. Arterioscler Thromb Vasc Biol 20: 2373-2378, 2000.
40. Shiojima I and Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90: 1243-1250, 2002.
41. Siddhanta A and Shields D. Secretory vesicle budding from the trans-Golgi network is mediated by phosphatidic acid levels. J Biol Chem 273: 17995-17998, 1998.
42. Stabile E, Zhou YF, Saji M, Castagna M, Shou M, Kinnaird TD, Baffour R, Ringel MD, Epstein SE, and Fuchs S. Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit. Circ Res 93: 1059-1065, 2003.
43. Tazawa S, Nakane T, and Chiba S. Angiotensin II type 1 receptor blockade prevents up-regulation of angiotensin II type 1A receptors in rat injured artery. J Pharmacol Exp Ther 288: 898-904, 1999.
44. Tulis DA, Mnjoyan ZH, Schiesser RL, Shelat HS, Evans AJ, Zoldhelyi P, and Fujise K. Adenoviral gene transfer of fortilin attenuates neointima formation through suppression of vascular smooth muscle cell proliferation and migration. Circulation 107: 98-105, 2003.
45. Uddin MR, Muthalif MM, Karzoun NA, Benter IF, and Malik KU. Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling. Hypertension 31: 242-247, 1998.
46. 1 receptor mediated. Arterioscler Thromb Vasc Biol 16: 857-863, 1996.
47. Virone-Oddos A, Desangle V, Provost D, Cazes M, Caussade F, and Cloarec A. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation. Br J Pharmacol 120: 488-494, 1997.
48. Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P, Li RK, Mickle DA, and Verma S. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 107: 1783-1790, 2003.
49. Yaghini FA, Zhang C, Parmentier JH, Estes AM, Jafari N, Schaefer SA, and Malik KU. Contribution of arachidonic acid metabolites derived via cytochrome P4504A to angiotensin II-induced neointimal growth. Hypertension 45: 1182-1187, 2005.
50. Yang HM, Kim HS, Park KW, You HJ, Jeon SI, Youn SW, Kim SH, Oh BH, Lee MM, Park YB, and Walsh K. Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling. Circulation 110: 301-308, 2004.
51. Zhang C, Yang J, Jacobs JD, and Jennings LK. Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: implications for vascular diseases. Am J Physiol Heart Circ Physiol 285: H2563-H2572, 2003.
52. Zhang C, Yang J, and Jennings LK. Attenuation of neointima formation through the inhibition of DNA repair enzyme PARP-1 in balloon-injured rat carotid artery. Am J Physiol Heart Circ Physiol 287: H659-H666, 2004.
53. Zhou RH, Lee TS, Tsou TC, Rannou F, Li YS, Chien S, and Shyy JY. Stent implantation activates Akt in the vessel wall: role of mechanical stretch in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23: 2015-2020, 2003.
54. Zhu J and Gao D. Losartan reduces collagen content and intimal thickening of iliac arteries after balloon injury in rabbits. J Renin Angiotensin Aldosterone Syst 1: 278-282, 2000.
55. Zoldhelyi P, McNatt J, Xu XM, Loose-Mitchell D, Meidell RS, Clubb FJ Jr, and Buja LM, Willerson JT, and Wu KK. Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene. Circulation 93: 10-17, 1996.
56. Zubilewicz T, Wronski J, Bourriez A, Terlecki P, Guinault AM, Muscatelli-Groux B, Michalak J, Melliere D, Becquemin JP, and Allaire E. Injury in vascular surgery-the intimal hyperplastic response. Med Sci Monit 7: 316-324, 2001.